Cambridge Investment Research Advisors
NVCR icon

Cambridge Investment Research Advisors’s NovoCure NVCR Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,029
Closed -$250K – 3232
2023
Q2 		$250K Buy
6,029
+807
+15% +$50.1K ﹤0.01% 2693
2023
Q1 		$314K Buy
5,222
+165
+3% +$13.2K ﹤0.01% 2448
2022
Q4 		$371K Sell
5,057
-312
-6% -$23.5K ﹤0.01% 2264
2022
Q3 		$408K Sell
5,369
-24
-0.4% -$1.87K ﹤0.01% 2103
2022
Q2 		$375K Sell
5,393
-283
-5% -$21.3K ﹤0.01% 2183
2022
Q1 		$470K Sell
5,676
-78
-1% -$5.75K ﹤0.01% 2157
2021
Q4 		$432K Buy
5,754
+84
+1% +$8.43K ﹤0.01% 2227
2021
Q3 		$659K Sell
5,670
-30
-0.5% -$4.54K ﹤0.01% 1833
2021
Q2 		$1.26M Sell
5,700
-514
-8% -$100K 0.01% 1364
2021
Q1 		$821K Sell
6,214
-227
-4% -$35.9K ﹤0.01% 1569
2020
Q4 		$1.11M Sell
6,441
-693
-10% -$94.8K 0.01% 1233
2020
Q3 		$794K Buy
7,134
+449
+7% +$35.9K 0.01% 1321
2020
Q2 		$396K Buy
6,685
+417
+7% +$27.4K ﹤0.01% 1689
2020
Q1 		$422K Buy
6,268
+3,608
+136% +$285K ﹤0.01% 1467
2019
Q4 		$224K Buy
+2,660
New +$215K ﹤0.01% 2124

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Cambridge Investment Research Advisors's NVCR Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 6,029 shares — an estimated $250K sold.

Cambridge Investment Research Advisors first reported a position in NVCR in Q4 2019 and held it in 15 quarters. The position peaked at $1.26M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6,029 NovoCure shares in Q3 2023, an estimated $250K.
  • Cambridge Investment Research Advisors first reported a position in NovoCure in Q4 2019 and held it in 15 quarters.
  • Cambridge Investment Research Advisors's NovoCure position peaked at $1.26M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.